Viewing StudyNCT00126893



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126893
Status: TERMINATED
Last Update Posted: 2007-05-15
First Post: 2005-08-03

Brief Title: Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia
Sponsor: Celgene Corporation
Organization: Celgene

Organization Data

Organization: Celgene
Class: INDUSTRY
Study ID: CC-401-AML-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Celgene Corporation
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators